Skip to main content

Security report for labiana.com

Labiana Life Sciences S.A. · Healthcare · Spain

Medium risk. 7 critical or high findings in Security headers, GDPR outside view and 2 other checks.

Security score

55/100

Risk levelMedium

0–100, higher is better. How it is calculated

Labiana Life Sciences S.A. is a well-established pharmaceutical company based in Spain, specializing in both animal and human health sectors. The company offers a broad portfolio of products and contract development and manufacturing services (CDMO), supported by multiple subsidiaries including Veterinarski Zavod Subotica and Zoleant Pharmaceuticals International. The website reflects a professional and consistent brand image, targeting pharmaceutical companies, investors, and health professionals. Technically, the site is built on WordPress with modern plugins and frameworks, providing a good user experience and mobile optimization. Security posture is strong with HTTPS and cookie consent mechanisms, though some security headers could be improved. Privacy compliance is robust with comprehensive policies and GDPR adherence. The absence of WHOIS data reduces domain trust slightly but does not detract from the overall credibility. Strategic recommendations include enhancing security headers, publishing a security policy, and improving accessibility.

Scanned

NIS2 and GDPR posture

GDPR outside view
65/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

7 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

    • High

      Third-party services without privacy policy

      Detected services: Google Analytics, Facebook, Twitter, LinkedIn, Google APIs

      What to do: Document all third-party data sharing in your privacy policy

Need hands-on remediation? Email guard@offseq.com

Keep watching labiana.com

This scan found 22 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
62
Security headers
15
Email security
85
DNS health
85
Network security
20
GDPR outside view
65
Average
55

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention labiana.com, from OffSeq Breach.

No leaked records found

Breach holds no records for labiana.com right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Labiana operates in the healthcare and pharmaceutical manufacturing sectors with a medium-sized footprint and a history dating back to 1958. It maintains a diversified business model combining product sales and contract manufacturing. The company is publicly listed and actively engages with investors, as evidenced by recent news and governance updates. Its subsidiaries expand its reach into biological products and generic pharmaceuticals. The company demonstrates strong market positioning in Spain and Europe, with a focus on quality and innovation. The website supports this positioning with detailed product and service information, legal compliance, and active social media channels.

Security posture

The website enforces HTTPS and implements GDPR-compliant cookie consent, indicating a mature approach to user privacy and security. However, no explicit security policy or incident response contacts are published, which could be a gap in transparency. Security headers are not detected in the HTML response, suggesting room for improvement in defense-in-depth. No vulnerable libraries or exposed sensitive data were found. The site uses reputable plugins and frameworks but should maintain regular updates to mitigate risks. Overall, the security posture is good but could be enhanced with formal policies and technical headers.

Recommendations

  1. Implement HTTP security headers such as Content-Security-Policy, X-Content-Type-Options, and X-Frame-Options to improve protection against common web attacks.
  2. Publish a dedicated security policy and incident response contact information to increase transparency and user trust.
  3. Regularly audit and update WordPress plugins and themes to prevent vulnerabilities from outdated components.
  4. Enhance website accessibility to meet WCAG standards, improving usability for all users and compliance.
  5. Consider establishing a vulnerability disclosure program or security.txt file to facilitate responsible reporting of security issues.

Contact details published on the site

Addresses
Legal name
Labiana Life Sciences S.A.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Labiana Life Sciences S.A.
Description
Labiana Life Sciences S.A. is a pharmaceutical company specializing in animal and human health products and services, including contract development and manufacturing. It has a long history since 1958 and operates multiple subsidiaries focused on biological products, pharmaceuticals, and nutritional supplements.
Key services
Contract Development and Manufacturing (CDMO), Animal Health Products, Human Health Products, Pharmaceutical manufacturing, Biological products development
Content quality
good
Branding
consistent

Technology

Stack
WordPress 6.8.1, WPBakery Page Builder, Slider Revolution 6.1.4, jQuery, Bootstrap, Google Tag Manager, Google Analytics, LazyLoad JS
Platforms
WordPress
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism implemented
  • No exposed sensitive data found in HTML

Analytics and tracking

Services
Google Analytics, Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Marketing tools
ShareThis
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content in Spanish and other languages
  2. Strong focus on pharmaceutical manufacturing and contract services
  3. Comprehensive privacy and cookie policies with GDPR compliance
  4. No visible security policy or incident response information
  5. No WHOIS data available, possibly due to domain privacy or recent registration
  6. Use of modern WordPress plugins and technologies
  7. Social media presence on LinkedIn, Facebook, Twitter, Instagram
  8. Contact information includes multiple physical addresses and phone numbers
  9. Cookie consent banner implemented with configuration options
Technical notes

Notes

The website is built on WordPress 6.8.1 using WPBakery Page Builder and Slider Revolution, indicating a modern CMS environment with drag-and-drop design capabilities. It leverages jQuery, Bootstrap, and Google Tag Manager for analytics and user interaction. Lazy loading is implemented for images, improving performance. The site is mobile optimized and uses responsive design. Performance is moderate, with potential for improvement in load times and accessibility. Hosting provider details are not explicitly found. SEO is supported by proper meta tags, Open Graph, and JSON-LD structured data, enhancing search engine visibility. Technical risks include reliance on third-party plugins which require maintenance to avoid vulnerabilities.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with labiana.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review labiana.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.